Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 107

Results For "IP"

11174 News Found

Rahul Pasumarthy joins Apollo Hospitals as Vice President – Apollo International
Hospitals | June 05, 2026

Rahul Pasumarthy joins Apollo Hospitals as Vice President – Apollo International

Healthcare industry leader returns to India to support Apollo Hospitals’ global expansion and advance the ‘Heal in India, Heal by India’ vision


Aurobindo Pharma launches TheraNym, India’s largest biologics CMO
Biopharma | June 05, 2026

Aurobindo Pharma launches TheraNym, India’s largest biologics CMO

MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market


CORONA Remedies spearheads green footprint campaign on World Environment Day
News | June 05, 2026

CORONA Remedies spearheads green footprint campaign on World Environment Day

The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices


Finerenone expands promise beyond diabetic kidney disease
Clinical Trials | June 05, 2026

Finerenone expands promise beyond diabetic kidney disease

The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized


SS Innovations sets world record with longest-distance robotic cardiac telesurgery
Medical Device | June 05, 2026

SS Innovations sets world record with longest-distance robotic cardiac telesurgery

The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres


Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment
Biopharma | June 05, 2026

Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment

Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe


Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials
Medical Device | June 05, 2026

Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials

Targeting deadly drug-resistant acinetobacter infections


Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS
People | June 05, 2026

Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS

Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness


ResMed acquires Noctrix Health for $340 million
Medical Device | June 04, 2026

ResMed acquires Noctrix Health for $340 million

Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio